Bimekizumab (Bimzelx; UCB Pharma) was approved by the FDA to treat psoriatic arthritis (PsA) on September 23, 2024, based on data from 2 phase 3 trials: BE OPTIMAL and BE COMPLETE.
On 9 month follow up CTA imaging, it was identified that the patient developed ossification of the posterior atlanto‐axial membrane and capsular ligaments ... monitor the patient to ensure that there ...
Psoriatic arthritis (PsA) is a seronegative inflammatory musculoskeletal disease that affects the peripheral joints, axial joints (spine) and entheses of subjects with psoriasis. PsA may lead to ...
Axial spondyloarthritis is a chronic rheumatological disease that primarily affects the sacroiliac joints and the spine, but often also involves the peripheral skeleton and other organs. The disease ...
Great fried chicken knows no borders – just ask the Malaysians coming to Singapore for a taste of Wingstop, a Texas-born brand. But obviously, there’s more to Singapore’s fried chicken scene than this ...
Joint pain—whether due to injury, infection, or arthritis—can make everyday activities uncomfortable, if not impossible. Addressing your joint pain and the inflammation that may be causing it ...
To investigate and evaluate the progression of myopia and associated factors of axial length (AL) growth among children in Chongqing. Methods: This six-month prospective study was conducted on ...